Skip to main content
SpringerLink
Log in

Cerebrovascular Structural Alterations/Dysautonomic Disorders in Diabetes Mellitus

  • Chapter
  • First Online:
Blood Pressure Disorders in Diabetes Mellitus

Part of the book series: Updates in Hypertension and Cardiovascular Protection ((UHCP))

  • 526 Accesses

Abstract

According to existing scientific evidence, diabetes mellitus is associated with mild to modest decrements in cognitive function. Domains of psychomotor speed, mental flexibility, attention, and general intelligence are those most frequently affected. Hypoglycemia is not usually risk factor for cognitive decline; however, this may not be true for children with young age at onset of diabetes. Relevant risk factors for the development of cognitive decline are an early age of onset and the presence of microvascular complications. Since age and duration of diabetes are important contributors to the changes in cognitive function, we need longitudinal studies looking at cognitive function, especially in elderly subject with type 1 diabetes mellitus. In addition, more information is needed in order to better understand the clinical implications of these mild-moderate decrements in cognitive function, also in terms of impact on daily lives and habits. In addition, the underlying mechanism and the risk factors that may lead to the development of more severe cognitive dysfunction like dementia in some, but not all diabetic patients are not clear.

Diabetic autonomic neuropathy (DAN) represents a particular aspect of diabetic neuropathy, which may lead to impairment of several organs, including the heart, both in type 1 and type 2 diabetic patients. The pathogenesis of DAN is not entirely clear, but metabolic, genetic, and hormonal factors may be involved; however, the final pathway probably involves oxidative stress and inflammation caused by hyperglycemia. Since no therapy was demonstrated to effectively reverse DAN, prevention with close glycemic control, multifactorial intervention, and lifestyle modification remain crucial.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Biessels GJ. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:64–74.

    PubMed  Google Scholar 

  2. Miles WR, Root HF. Psychologic tests applied to diabetic patients. Arch Intern Med. 1922;30:767.

    Google Scholar 

  3. Dejong R. The nervous system complications of diabetes mellitus, with special reference to cerebrovascular changes. J Nerv Ment Dis. 1950;111:181–206.

    Google Scholar 

  4. Mijnhout GS, Scheltens P, Diamant M, Biessels GJ, Wessels AM, Simsek S, et al. Diabetic encephalopathy: a concept in need of a definition. Diabetologia. 2006;49:1447–8.

    CAS  PubMed  Google Scholar 

  5. Moheet A, Mangia S, Seaquist ER. Impact of diabetes on cognitive function and brain structure. Ann N Y Acad Sci. 2015;1353:60–71.

    PubMed  PubMed Central  Google Scholar 

  6. Qureshi AI, Caplan LR. Intracranial atherosclerosis. Lancet. 2014;383(9921):984–98.

    PubMed  Google Scholar 

  7. Ergul A, Kelly-Cobbs A, Abdalla M, Fagan SC. Cerebrovascular complications of diabetes: focus on stroke. Endocr Metab Immune Disord Drug Targets. 2012;12:148–58.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol. 2020;8:325–36.

    PubMed  Google Scholar 

  9. Bell DSH, Goncalves E. Stroke in the patient with diabetes (Part 1)—epidemiology, etiology, therapy and prognosis. Diabetes Res Clin Pract. 2020;164:108193.

    PubMed  Google Scholar 

  10. Kodl C, Franc D, Rao J, et al. Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes. 2008;57:3083–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Mangia S, Kumar AF, Moheet AA, Roberts RJ, Eberly LE, Seaquist ER, et al. Neurochemical profile of patients with type 1 diabetes measured by H-1-MRS at 4 T. J Cereb Blood Flow Metab. 2013;33:754–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Fang F, Zhan YF, Zhuo YY, Yin DZ, Li KA, Wang YF. Brain atrophy in middle-aged subjects with type 2 diabetes mellitus, with and without microvascular complications. J Diabetes. 2018;10:625–32.

    Google Scholar 

  13. Moran C, Phan TG, Chen J, Blizzard L, Beare R, Venn A, et al. Brain atrophy in type 2 diabetes regional distribution and influence on cognition. Diabetes Care. 2013;36:4036–42.

    Google Scholar 

  14. den Heijer T, Vermeer SE, van Dijk EJ, Prins ND, Koudstaal PJ, Hofman A, et al. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia. 2003;46:1604–10.

    Google Scholar 

  15. Mankovsky B, Zherdova N, van den Berg E, Biessels GJ, de Bresser J. Cognitive functioning and structural brain abnormalities in people with Type 2 diabetes mellitus. Diabet Med. 2018;35:1663–70.

    CAS  PubMed  Google Scholar 

  16. Sanjari Moghaddam H, Ghazi Sherbaf F, Aarabi MH. Brain microstructural abnormalities in type 2 diabetes mellitus: A systematic review of diffusion tensor imaging studies. Front Neuroendocrinol. 2019;55:100782.

    PubMed  Google Scholar 

  17. Horton WB, Barrett EJ. Microvascular dysfunction in diabetes mellitus and cardiometabolic disease. Endocr Rev. 2021;42:29–55.

    PubMed  Google Scholar 

  18. Manolis AJ, Kallistratos MS, Vlahakos DS, Mitrakou A, Poulimenos LE. Comorbidities often associated with brain damage in hypertension: diabetes, coronary artery disease, chronic kidney disease and obstructive sleep apnea. In: Coca A, editor. Hypertension and brain damage. Springer Switzerland; 2016. p. 35–46.

    Google Scholar 

  19. Zhao X, Han Q, Gang X, Wang G. Altered brain metabolites in patients with diabetes mellitus and related complications—evidence from 1H MRS study. Biosci Rep. 2018;38(5):BSR20180660.

    PubMed  PubMed Central  Google Scholar 

  20. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RPC. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care. 2005;28:726–35.

    PubMed  Google Scholar 

  21. Gaudieri PA. Cognitive function in children with type 1 diabetes: a meta-analysis. Diabetes Care. 2008;31:1892–7.

    PubMed  PubMed Central  Google Scholar 

  22. Jacobson A, Musen G, Ryan C, Silvers N, Cleary P, Waberski B, et al. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med. 2007;356:1842–52.

    PubMed  Google Scholar 

  23. Reichard P, Pihl M, Rosenqvist U, Sule J. Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up. Diabetologia. 1996;39:1483–8.

    CAS  PubMed  Google Scholar 

  24. Rawlings AM, Sharrett AR, Schneider ALC, Coresh J, Albert M, Couper D, et al. Diabetes in midlife and cognitive change over 20 years: a cohort study. Ann Intern Med. 2014;161:785–93.

    PubMed  PubMed Central  Google Scholar 

  25. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia—the Rotterdam study. Neurology. 1999;53:1937–42.

    CAS  PubMed  Google Scholar 

  26. van den Berg E, Kloppenborg RP, Kessels RPC, Kappelle LJ, Biessels GJ. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: a systematic comparison of their impact on cognition. Biochim Biophys Acta. 2009;1792:470–81.

    PubMed  Google Scholar 

  27. Palta P, Schneider ALC, Biessels GJ, Touradji P, Hill-Briggs F. Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J Int Neuropsychol Soc. 2014;20:278–91.

    PubMed  PubMed Central  Google Scholar 

  28. Hajek T, McIntyre R, Alda M. Bipolar disorders, type 2 diabetes mellitus, and the brain. Curr Opin Psychiatry. 2016;29:1–6.

    PubMed  Google Scholar 

  29. Zilliox LA, Chadrasekaran K, Kwan JY, Russell JW. Diabetes and cognitive impairment. Curr Diab Rep. 2016;16:87.

    PubMed  PubMed Central  Google Scholar 

  30. Cameron FJ, Northam EA, Ryan CM. The effect of type 1 diabetes on the developing brain. Lancet Child Adolesc Health. 2019;3:427–36.

    PubMed  Google Scholar 

  31. Agabiti-Rosei E, Rizzoni D, Cunha P. Pathophysiology of brain damage in hypertension. In: Coca A, editor. Hypertension and brain damage. Springer Switzerland; 2016. p. 47–60.

    Google Scholar 

  32. De Ciuceis C. Microvascular alterations in diabetes: focus on small resistance arteries. In: Agabiti-Rosei E, Heagerty AM, Rizzoni D, editors. Microcirculation in cardiovascular diseases. Springer Switzerland; 2020. p. 149–64.

    Google Scholar 

  33. Muriach M, Flores-Bellver M, Romero FJ, Barcia JM. Diabetes and the brain: oxidative stress, inflammation, and autophagy. Oxid Med Cell Longev. 2014;2014:102158.

    PubMed  PubMed Central  Google Scholar 

  34. Bogush M, Heldt NA, Persidsky. Blood brain barrier injury in diabetes: unrecognized effects on brain and cognition. J Neuroimmune Pharmacol. 2017;12:593–601.

    PubMed  PubMed Central  Google Scholar 

  35. Goldwaser EL, Acharya NK, Sarkar A, Godsey G, Nagele RG. Breakdown of the cerebrovasculature and blood-brain barrier: a mechanistic link between diabetes mellitus and Alzheimer's disease. J Alzheimers Dis. 2016;54:445–56.

    PubMed  Google Scholar 

  36. Li W, Risacher SL, Huang E, Saykin AJ, Alzheimer's Disease Neuroimaging Initiative. Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort. Neurology. 2016;87:595–600.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Biessels GJ. Cerebral complications of diabetes: clinical findings and pathogenetic mechanism. Neth J Med. 1999;54:35–45.

    CAS  PubMed  Google Scholar 

  38. Talbot F, Nouwen A. A review of the relationship between depression and diabetes in adults. Diabetes Care. 2000;23:1556–62.

    CAS  PubMed  Google Scholar 

  39. Said G. Diabetic neuropathy. Handb Clin Neurol. 2013;115:579–89.

    PubMed  Google Scholar 

  40. Verrotti A, Prezioso G, Scattoni R, Chiarelli F. Autonomic neuropathy in diabetes mellitus. Front Endocrinol (Lausanne). 2014;5:205.

    PubMed  Google Scholar 

  41. Pasnoor M, Dimachkie MM, Kluding P, Barohn RJ. Diabetic neuropathy part1:overview and symmetric phenotypes. Neurol Clin. 2013;31:425–45.

    PubMed  PubMed Central  Google Scholar 

  42. Boulton AJ, Gries FA, Jervell JA. Guidelines for diagnosis and outpatient management of diabetic peripheral neuropathy. Diabetes Metab. 1998;15:508–14.

    CAS  Google Scholar 

  43. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285–93.

    PubMed  PubMed Central  Google Scholar 

  44. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years’ experience in diabetes. Diabetes Care. 1985;8:491–8.

    CAS  PubMed  Google Scholar 

  45. Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care. 2010;33:434–41.

    PubMed  PubMed Central  Google Scholar 

  46. Pavy-LeTraon A, Fontaine S, Tap G, Guidolin B, Senard JM, Hanaire H. Cardiovascular autonomic neuropathy and other complications in type 1 diabetes. Clin Auton Res. 2010;20:153–60.

    Google Scholar 

  47. Tantucci C, Scionti L, Bottini P, Dottorini ML, Puxeddu E, Casucci G, et al. Influence of autonomic neuropathy of different severities on the hypercapnic drive to breathing in diabetic patients. Chest. 1997;112:145–53.

    CAS  PubMed  Google Scholar 

  48. Fujihara K, Kodama S, Horikawa C, Yoshizawa S, Sugawara A, Hirasawa R, et al. The relationship between diabetic neuropathy and sleep apnea syndrome: a meta-analysis. Sleep Disord. 2013;2013:150371.

    PubMed  PubMed Central  Google Scholar 

  49. Chandrasekharan B, Srinivasan S. Diabetes and the enteric nervous system. Neurogastroenterol Motil. 2007;19:951–60.

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Chang J, Rayner CK, Jones KL, Horowitz M. Diabetic gastroparesis—backwards and forwards. J Gastroenterol Hepatol. 2011;26(Suppl 1):46–57.

    PubMed  Google Scholar 

  51. Tang M, Donaghue KC, Cho YH, Craig ME. Autonomic neuropathy in young people with type 1 diabetes: a systematic review. Pediatr Diabetes. 2013;14:239–48.

    PubMed  Google Scholar 

  52. Tentolouris N, Marinou K, Kokotis P, Karanti A, Diakoumopoulou E, Katsilambros N. Sudomotor dysfunction is associated with foot ulceration in diabetes. Diabet Med. 2009;26:302–5.

    CAS  PubMed  Google Scholar 

  53. Vinik AI, Erbas T. Diabetic autonomic neuropathy. Handb Clin Neurol. 2013;117:279–94.

    PubMed  Google Scholar 

  54. Dimitropoulos G, Tahrani AA, Stevens MJ. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes. 2014;5:17–39.

    PubMed  PubMed Central  Google Scholar 

  55. Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003;26:1895–901.

    PubMed  Google Scholar 

  56. Ziegler D, Gries FA, Spüler M, Lessmann F. The epidemiology of diabetic neuropathy. J Diabetes Complications. 1992;6:49–57.

    CAS  PubMed  Google Scholar 

  57. Frontoni S, Bracaglia D, Gigli F. Relationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes. Nutr Metab Cardiovasc Dis. 2005;15:441–9.

    PubMed  Google Scholar 

  58. Ejskjaer N, Arif S, Dodds W, Zanone MM, Vergani D, Watkins PJ, et al. Prevalence of autoantibodies to autonomic nervous tissue structures in type 1diabetes mellitus. Diabet Med. 1999;16:544–9.

    CAS  PubMed  Google Scholar 

  59. Schmidt RE, Dorsey DA, Beaudet LN, Plurad SB, Parvin CA, Ohara S. Effect of IGF-I and neurotrophin-3 on gracile neuroaxonal dystrophy in diabetic and aging rats. Brain Res. 2000;876:88–94.

    CAS  PubMed  Google Scholar 

  60. Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev. 2012;6:CD007543.

    PubMed  Google Scholar 

  61. Lee SS, Han HS, Kim H. A 5-yr follow-up nerve conduction study for the detection of subclinical diabetic neuropathy in children with newly diagnosed insulin-dependent diabetes mellitus. Pediatr Diabetes. 2010;11:521–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy

    Damiano Rizzoni & Paolo Desenzani

  2. Clinica Medica, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy

    Damiano Rizzoni

Authors
  1. Damiano Rizzoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paolo Desenzani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Damiano Rizzoni .

Editor information

Editors and Affiliations

  1. American University of Beirut Medical Center, Beirut, Lebanon

    Adel E. Berbari

  2. University of Milano-Bicocca, Milano, Italy

    Giuseppe Mancia

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rizzoni, D., Desenzani, P. (2023). Cerebrovascular Structural Alterations/Dysautonomic Disorders in Diabetes Mellitus. In: Berbari, A.E., Mancia, G. (eds) Blood Pressure Disorders in Diabetes Mellitus. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-031-13009-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-13009-0_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-13008-3

  • Online ISBN: 978-3-031-13009-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation